In plain language
GHRP-6 is one of the first synthetic growth hormone releasing peptides, acting on the ghrelin receptor to stimulate growth hormone and strongly increase appetite. It has been used in human pharmacology research but is not an approved medicine. Evidence for wellness and performance uses is limited.
What it is explored for
GHRP-6 is one of the original growth hormone releasing peptides, reliably prompting a GH pulse and famous for its strong appetite-stimulating effect through the ghrelin receptor. It has a useful place in human pharmacology research, though controlled trials for muscle, recovery, or anti-aging uses are limited, so the wellness evidence remains early. Here is where interest is highest.
- Stimulating natural growth hormone release
- Appetite stimulation research
- Recovery and lean-mass interest
- Pairing with GHRH analogs
- Growth hormone pharmacology research
These are areas of active interest and reported use, not proven outcomes. This peptide carries a limited evidence rating, see the evidence summary below for how strong the science actually is.
How it works
GHRP-6 activates the growth hormone secretagogue (ghrelin) receptor, prompting growth hormone release and stimulating appetite, and it works synergistically with GHRH.
- Ghrelin receptor agonism. Stimulates the GHS receptor to trigger a pulse of growth hormone release.
- Strong appetite stimulation. Among the secretagogues it produces some of the most pronounced hunger effects via ghrelin signaling.
- Synergy with GHRH. Paired with a GHRH analog it amplifies the growth hormone pulse in human pharmacology studies.
GH-release and appetite effects are documented in early human studies; broader wellness outcomes are not established by controlled trials.
Evidence summary
GHRP-6 has been characterized in early human pharmacology and reliably raises growth hormone while strongly stimulating appetite. However, there are no published, well-controlled trials supporting marketed uses for muscle, recovery, or anti-aging, and its pronounced appetite and secondary hormone effects limit its appeal.
Reported safety & side effects
Short-term reports describe it as generally tolerated, with strong appetite increase, flushing, and modest cortisol and prolactin rises among common effects. Long-term human safety is not established.
Stacking notes
Full stacking guideMK-677 already raises growth hormone and IGF-1 strongly on its own. Adding another secretagogue compounds water retention, appetite, and insulin-resistance effects for little clear added benefit.
MK-677IpamorelinStacking two peptides that hit the same ghrelin receptor (for example ipamorelin with GHRP-6 or hexarelin) is largely redundant and increases hunger, cortisol, and prolactin without a clear reason.
IpamorelinGeneral educational guidance, not medical advice. Combination evidence is limited; any stack should involve a qualified clinician.
Frequently asked
Is GHRP-6 FDA-approved?
No. GHRP-6 is not approved by the FDA for any use. It is sold as a research chemical and is not an approved medicine.
Why is GHRP-6 known for hunger?
It strongly activates the ghrelin receptor, and ghrelin is the body's hunger hormone, so a pronounced increase in appetite is a hallmark effect, more so than with most other secretagogues.
How does it compare to GHRP-2?
Both act on the ghrelin receptor, but GHRP-6 generally produces a stronger appetite effect, while GHRP-2 is often described as a somewhat more potent GH releaser at comparable doses. Neither is approved for wellness use.